[go: up one dir, main page]

BR9612115A - Inibidor de proliferação de célula endotelial e processo de uso - Google Patents

Inibidor de proliferação de célula endotelial e processo de uso

Info

Publication number
BR9612115A
BR9612115A BR9612115A BR9612115A BR9612115A BR 9612115 A BR9612115 A BR 9612115A BR 9612115 A BR9612115 A BR 9612115A BR 9612115 A BR9612115 A BR 9612115A BR 9612115 A BR9612115 A BR 9612115A
Authority
BR
Brazil
Prior art keywords
cell proliferation
endothelial cell
proliferation inhibitor
inhibitor
endothelial
Prior art date
Application number
BR9612115A
Other languages
English (en)
Inventor
Judah Folkamm
Yihai Cao
Michael S O'reilly
Original Assignee
Childrens Medical Center
Moses
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/763,528 external-priority patent/US5854221A/en
Application filed by Childrens Medical Center, Moses filed Critical Childrens Medical Center
Publication of BR9612115A publication Critical patent/BR9612115A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Farming Of Fish And Shellfish (AREA)
BR9612115A 1995-12-13 1996-12-13 Inibidor de proliferação de célula endotelial e processo de uso BR9612115A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US851995P 1995-12-13 1995-12-13
US08/763,528 US5854221A (en) 1996-12-12 1996-12-12 Endothelial cell proliferation inhibitor and method of use
PCT/US1996/020447 WO1997023500A1 (en) 1995-12-13 1996-12-13 Endothelial cell proliferation inhibitor and method of use

Publications (1)

Publication Number Publication Date
BR9612115A true BR9612115A (pt) 1999-02-17

Family

ID=26678280

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612115A BR9612115A (pt) 1995-12-13 1996-12-13 Inibidor de proliferação de célula endotelial e processo de uso

Country Status (19)

Country Link
US (1) US20010016644A1 (pt)
EP (1) EP0869970B1 (pt)
JP (1) JP3684371B2 (pt)
KR (1) KR100477280B1 (pt)
CN (1) CN1554444A (pt)
AT (1) ATE262537T1 (pt)
AU (1) AU710612B2 (pt)
BR (1) BR9612115A (pt)
CA (1) CA2240296C (pt)
CZ (1) CZ298612B6 (pt)
DE (1) DE69631972T2 (pt)
DK (1) DK0869970T3 (pt)
ES (1) ES2217340T3 (pt)
HU (1) HUP9900979A3 (pt)
NO (1) NO321775B1 (pt)
NZ (1) NZ330537A (pt)
PL (1) PL188719B1 (pt)
PT (1) PT869970E (pt)
WO (1) WO1997023500A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0869970T3 (da) * 1995-12-13 2004-07-05 Abbott Lab Endothelcelleprolifereringsinhibitor og dens anvendelse
WO1997041824A2 (en) * 1996-05-03 1997-11-13 Abbott Laboratories Antiangiogenic peptides derived from plasminogen
US5801146A (en) * 1996-05-03 1998-09-01 Abbott Laboratories Compound and method for inhibiting angiogenesis
US6699838B1 (en) 1996-05-03 2004-03-02 Abbott Laboratories Antiangiogenic peptides
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
EP1001985A1 (en) * 1997-06-26 2000-05-24 Karolinska Innovations AB Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
AU1598599A (en) * 1997-11-20 1999-06-15 Genetix Pharmaceuticals, Inc. Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
JP4209086B2 (ja) * 1999-05-17 2009-01-14 コンジュケム バイオテクノロジーズ インコーポレイテッド 長期持続性抗新脈管形成ペプチド
US7144854B1 (en) 1999-09-10 2006-12-05 Conjuchem, Inc. Long lasting anti-angiogenic peptides
WO2000069911A1 (en) 1999-05-17 2000-11-23 Conjuchem, Inc. Long lasting insulinotropic peptides
WO2001044294A2 (en) * 1999-12-15 2001-06-21 Entremed, Inc. Compositions and methods for inhibiting endothelial cell proliferation
WO2002020813A2 (en) 2000-09-05 2002-03-14 Karolinska Innovations Ab Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
WO2002040510A2 (en) * 2000-11-02 2002-05-23 Bristol-Myers Squibb Company Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
WO2005072341A2 (en) * 2004-01-21 2005-08-11 Fujirebio America, Inc. Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
CN100355458C (zh) * 2005-03-16 2007-12-19 北京大学 人增殖抑制基因－腺病毒表达载体的应用
WO2010138631A1 (en) 2009-05-26 2010-12-02 Biolex Therapeutics, Inc. Compositions and methods for production of aglycosylated plasminogen
CN103060265B (zh) * 2013-01-23 2014-12-03 山东大学 老年大鼠脑血管内皮细胞原代培养方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
EP0589181A3 (en) * 1992-07-30 1995-02-22 Yeda Res & Dev Synthetic vitronectin derivatives and their pharmaceutical compositions.
CN1309833C (zh) * 1994-04-26 2007-04-11 儿童医学中心公司 血管生成抑制素及其在制备药物中的用途
JPH09512426A (ja) * 1994-04-26 1997-12-16 ファルマシア・アンド・アップジョン・カンパニー 好中球の接着および移動の遮断に有用なＭａｃ−１ Ｉ−ドメイン蛋白質
ES2292174T3 (es) * 1995-04-26 2008-03-01 The Children's Medical Center Corporation Fragmentos de angiostatina y procedimientos de utilizacion.
DK0869970T3 (da) * 1995-12-13 2004-07-05 Abbott Lab Endothelcelleprolifereringsinhibitor og dens anvendelse

Also Published As

Publication number Publication date
CN1554444A (zh) 2004-12-15
HK1017692A1 (zh) 1999-11-26
CZ182898A3 (cs) 1998-10-14
ES2217340T3 (es) 2004-11-01
EP0869970A4 (en) 2002-01-30
DE69631972D1 (de) 2004-04-29
CA2240296C (en) 2004-05-04
ATE262537T1 (de) 2004-04-15
JP3684371B2 (ja) 2005-08-17
NO982715D0 (no) 1998-06-12
DE69631972T2 (de) 2005-01-05
HUP9900979A3 (en) 2001-10-29
JP2002502359A (ja) 2002-01-22
EP0869970B1 (en) 2004-03-24
NO982715L (no) 1998-08-12
NZ330537A (en) 2001-06-29
HUP9900979A2 (hu) 1999-07-28
AU1687097A (en) 1997-07-17
EP0869970A1 (en) 1998-10-14
PL188719B1 (pl) 2005-04-29
PL327200A1 (en) 1998-11-23
CA2240296A1 (en) 1997-07-03
KR100477280B1 (ko) 2005-07-18
DK0869970T3 (da) 2004-07-05
WO1997023500A1 (en) 1997-07-03
NO321775B1 (no) 2006-07-03
KR19990072126A (ko) 1999-09-27
US20010016644A1 (en) 2001-08-23
CZ298612B6 (cs) 2007-11-21
PT869970E (pt) 2004-08-31
AU710612B2 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
BR9612115A (pt) Inibidor de proliferação de célula endotelial e processo de uso
ES2101499T3 (es) Fibras.
BR9707049A (pt) Agentes anticoagulantes utilizáveis no tratamento de trombose
DE69818049D1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
DE69332770D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfamidsäuren verwendbar als retrovirale Proteasehemmer
EP0675728A4 (en) MEANS AND METHODS FOR IMPROVING KERATINOYCTE ADHESION TO THE SKIN.
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
ES2089186T3 (es) Reflectores de pelicula de magnesio.
AR001732A1 (es) Celulasa alcalina novedosa y método para producirla
DE69634077D1 (de) Haemophilus adhäsionsproteinen
ATE170631T1 (de) Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
DE69434424D1 (de) In vitro kulturprozess für verschiedene stadien von gewebeparasiten
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
ATA136995A (de) Abreicherung von 7-adca in 3-vinyl-aca
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
ES2062754T3 (es) Eliminacion de linfocitos activados.
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DE69635457D1 (de) Deprenyl induziertes protein
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
ATE170292T1 (de) Nachweis von antibiotika
DE59611353D1 (de) Transketolase-verwandtes protein
FR2703066B1 (fr) Procédé d'intégration en milieu écologique et compositions pour sa mise en Óoeuvre.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, COM BASE NOS ARTS. 8, 10 (IX), 11 E 37O.

B12B Appeal against refusal [chapter 12.2 patent gazette]